The extent to which ALT was elevated was similar across these two different patient groups, but the proportion with an elevated level was higher in the obesity group (52%) than in the group with diabetes and high cardiovascular risk (41%). This evidence concerns the gene GPT and obesity due to melanocortin 4 receptor deficiency.